Showing results (151-160 of 586) with videos related to

Sort By:
Pageof 59
Journal of the American Heart Association|November 11, 2024
Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral AnticoagulationJulia Aulin, Karl Sjölin, Johan Lindbäck, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 8, 2008
Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarctionAnders Mälarstig, Snaevar Sigurdsson, Per Eriksson, et al.
The American Journal of Cardiology|August 19, 2015
Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)Rangadham Nagarakanti, Lars Wallentin, Herbert Noack, et al.
BMJ (Clinical Research Ed.)|August 9, 2015
Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registriesSheng-Chia Chung, Johan Sundström, Chris P Gale, et al.
American Heart Journal|December 8, 2022
Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registryMikolaj Skibniewski, Dimitrios Venetsanos, Anders Ahlsson, et al.
Stroke|April 12, 2012
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trialRobert G Hart, Hans-Christoph Diener, Sean Yang, et al.
European Heart Journal|December 7, 2007
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery diseaseLars Wallentin, Christoph Varenhorst, Stefan James, et al.
Nature Reviews. Cardiology|February 27, 2013
Prognostic relevance of PCI-related myocardial infarctionPier Woudstra, Maik J Grundeken, Tim P van de Hoef, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trialLars-Åke Levin, Lars Wallentin, Lars Bernfort, et al.
American Heart Journal|May 16, 2016
Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)David Erlinge, Sasha Koul, Peter Eriksson, et al.
Pageof 59